Related Articles
Immunization with MHC class I-negative but not -positive HPV16-associated tumour cells inhibits growth of MHC class I-negative tumours
Tumour MHC class I downregulation and immunotherapy (Review)
Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours
Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy
Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer